Kaiser Permanente is a clinical research site located in Honolulu, Hawaii, United States 96819.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Kaiser Permanente has participated in 21 clinical trials with 4 currently active.
Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, HER2-positive Breast Cancer, Type 2 Diabetes Mellitus.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Kaiser Permanente.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Hawaii · View every site in Honolulu
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kaiser Permanente has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Permanente has 21 clinical trials on record, with 4 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, HER2-positive Breast Cancer, Type 2 Diabetes Mellitus.
Kaiser Permanente has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.